Furthermore, in matched pairs, the activity of breast-cancer-related pathways (e.g., PTEN, Tp53, BRCA1, Her2, and Cyclin D1) in the PDTXs was correlated with and predicted the activity scores in the originating breast cancer samples (Figure S1D). Here, CCND1 is linked to breast cancer.